Home / Stocks / OTLC

OTLC insider trading

Oncotelic Therapeutics, Inc. — open-market insider buys and $1M+ sells from SEC Forms 3, 4 and 5.
Insider buys · 24 mo
7
Bought · 24 mo
$60k
Buys · last 90 days
4 · $38k
Most recent buy
2026-07-02

Cluster buy detected

3 insiders bought OTLC within a short window (2026-06-15→2026-07-01), $38k in total — cluster score 55/100. Members see the buyers, the score breakdown and the chart.

See the cluster

Recent insider filings

FiledInsiderTypeSharesPriceValue
2026-07-02Trieu Vuongcluster
CHAIRMAN AND CEO
Bought240,000$0.04$10k
2026-06-24Trieu Vuongcluster
CHAIRMAN AND CEO
Bought255,000$0.05$13k
2026-06-22Shah Amit B.cluster
CFO
Bought20,000$0.05$1k
2026-06-17Trieu Vuongcluster
CHAIRMAN AND CEO
Bought335,759$0.04$14k
2025-07-10Trieu Vuong
CHAIRMAN AND CEO
Bought198,737$0.01$2k
2025-01-31Trieu Vuong
CHAIRMAN AND CEO
Bought346,844$0.03$10k
2024-11-26Trieu Vuong
CHAIRMAN AND CEO
Bought298,499$0.03$9k

Most active insider buyers

InsiderRoleBuysTotal bought
Trieu VuongCHAIRMAN AND CEO6$59k
Shah Amit B.CFO1$1k

See OTLC on the chart

Every insider buy and sell for OTLC plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.

Open the browserFree sample
Data from the SEC EDGAR ownership filings, refreshed daily. Only open-market purchases (transaction code P) and sales of $1M or more are shown; grants, option exercises and tax withholding are excluded because they run on schedules set years earlier. Not investment advice.